Patent · US Active

HNF4A saRNA compositions and methods of use

US11162099B2 · kind B2 · utility

0Cited by

2References

4Claims

0Family size

Assignee

MiNA Therapeutics Limited · GB

Inventors

Hans E. Huber · Lansdale, US
David Charles Blakey · Macclesfield, GB
Jon Voutila · London, GB
Monika Krampert · Bamberg, DE
Markus Hossbach · Kulmbach, DE

Key dates

Filing date	Sep 7, 2018
Grant date	Nov 2, 2021
Priority date	—
Expiry date	Sep 7, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2320/32
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to saRNA targeting an HNF4a transcript and therapeutic compositions comprising said saRNA. Methods of using the therapeutic compositions are also provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.